Allogene Therapeutics Inc (ALLO)
$1.18 -5.60% Close Oct 30, 2026 Live
Allogene Therapeutics stock today
Allogene Therapeutics closed at $1.18 on October 30, 2026, down 5.60% on the day. Over the past year it returned -2.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $407 million.
$1.00$2.00$3.00
NovJan 2026MarMayJulSep
| Period | ALLO | S&P 500 (SPY) |
|---|---|---|
| 1 month | -26.3% | -0.9% |
| 3 months | -40.1% | +2.1% |
| Year to date | -13.9% | +11.7% |
| 1 year | -2.5% | +12.4% |
| 3 years | -57.2% | +88.5% |
| 5 years | -93.2% | +76.0% |
Key statistics
- Market value
- $407M
- Price / sales
- 87.7
- 52-week range
- $1.05 to $3.06
- Next report
- Nov 5, 2026
About Allogene Therapeutics
Allogene Therapeutics develops allogeneic chimeric antigen receptor T-cell therapies for blood cancers.
Sector: Health Care
More on Allogene Therapeutics
- Financials: revenue, earnings and segmentsRevenue -77% in the year to Dec 2024
- Returns: what $1,000 became$1,000 five years ago is $68.44 today
No forecast, no recommendation. This page describes Allogene Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.